Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4r)-4-(3-((1s)-1-(4-amino-3-methyl-1h-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
2. 2-pyrrolidinone, 4-(3-((1s)-1-(4-amino-3-methyl-1h-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, (4r)-
3. Incb050465
1. 1426698-88-5
2. Incb050465
3. Parsaclisib [inn]
4. Parsaclisib [usan]
5. Incb-050465
6. Os7097575k
7. (4r)-4-[3-[(1s)-1-(4-amino-3-methylpyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl]pyrrolidin-2-one
8. (4r)-4-(3-((1s)-1-(4-amino-3-methyl-1h-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
9. 2-pyrrolidinone, 4-(3-((1s)-1-(4-amino-3-methyl-1h-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, (4r)-
10. Parsaclisib (usan/inn)
11. Parsaclisib [usan:inn]
12. Incb050465 Free Base
13. Parsaclisib [who-dd]
14. Incb-050465 Free Base
15. Parsaclisib (incb050465)
16. Chembl4297615
17. Schembl14736228
18. Unii-os7097575k
19. Bdbm272573
20. Ex-a2638
21. Who 10589
22. Db14867
23. Ac-36916
24. Us10065963, 32c
25. Hy-109068
26. Cs-0033435
27. D11437
28. (r)-4-(3-((s)-1-(4-amino-3-methyl-1h-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
| Molecular Weight | 432.9 g/mol |
|---|---|
| Molecular Formula | C20H22ClFN6O2 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 432.1476798 g/mol |
| Monoisotopic Mass | 432.1476798 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 632 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of mature B-cell malignancies
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Parsaclisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Parsaclisib, including repackagers and relabelers. The FDA regulates Parsaclisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Parsaclisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Parsaclisib supplier is an individual or a company that provides Parsaclisib active pharmaceutical ingredient (API) or Parsaclisib finished formulations upon request. The Parsaclisib suppliers may include Parsaclisib API manufacturers, exporters, distributors and traders.
Parsaclisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Parsaclisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Parsaclisib GMP manufacturer or Parsaclisib GMP API supplier for your needs.
A Parsaclisib CoA (Certificate of Analysis) is a formal document that attests to Parsaclisib's compliance with Parsaclisib specifications and serves as a tool for batch-level quality control.
Parsaclisib CoA mostly includes findings from lab analyses of a specific batch. For each Parsaclisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Parsaclisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Parsaclisib EP), Parsaclisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Parsaclisib USP).
LOOKING FOR A SUPPLIER?
